Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Breast Cancer Research and Treatment|July 27, 2015
The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measureM Jebbink, E van Werkhoven, I A M Mandjes, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 4, 2019
Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort studyM M Frijstein, Car Lok, N E van Trommel, et al.
Breast (Edinburgh, Scotland)|April 27, 2018
Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)M E M van der Noordaa, F H van Duijnhoven, C E Loo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
ESMO Open|December 9, 2022
Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?N S IJzerman, E van Werkhoven, M Mohammadi, et al.
Breast Cancer Research and Treatment|October 25, 2020
Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trialD B Raphael Daniela, N S Russell, E van Werkhoven, et al.
BMC Cancer|September 11, 2019
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparibR de Haan, E van Werkhoven, M M van den Heuvel, et al.
British Journal of Cancer|October 24, 2013
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancerL S Rigter, C E Loo, S C Linn, et al.
Breast Cancer Research and Treatment|December 23, 2016
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcomeA H M de Vries Schultink, X Alexi, E van Werkhoven, et al.
The British Journal of Surgery|June 22, 2021
Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancerM E M van der Noordaa, F H van Duijnhoven, F N E Cuijpers, et al.
Pageof 4